Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-06

FDA Approved: CIPROFLOXACIN AND DEXAMETHASONE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Ciprofloxacin hydrochloride and dexamethasone under an original application from Upsher-Smith Laboratories, for otic use to treat ear infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin hydrochloride and dexamethasone (Ciprofloxacin hydrochloride and dexamethasone)

Snippet

ORIG AP for CIPROFLOXACIN AND DEXAMETHASONE (CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE)